Tilray Brands, Inc. NEW YORK and LEAMINGTON, Ontario, June 10, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the vote for an amendment of the Company’s Fifth
David O’Reilly; Chief Executive Officer, Director; Howard Hughes Holdings Inc L Cross; President; Howard Hughes Holdings Inc Carlos Olea; Chief Financial Officer and Principal Financial Officer; Howard Hughes Holdings Inc Operator Thank you for standing by and welcome to the Howard Hughes Management’s first quarter 2025 earnings conference call. (Operator Instructions) As a reminder, today’s
Unity Biotechnology, Inc. SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2025. UNITY announced 24-week and partial 36-week topline data from our Phase 2b
Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and strategic partnerships. NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 31, 2025 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals” or “Conduit” or the “Company”) today
Updated Phase 1 data for ELVN-001 expected mid-2025 as positive enrollment momentum continues Expected monotherapy and combination data from the ELVN-002 Phase 1 trials in second half of 2025 Strong balance sheet with $313 million in cash, cash equivalents and marketable securities, which is expected to provide cash runway into mid-2027 BOULDER, Colo., Mar. 13, 2025
10x Genomics’ ATAC-Seq patents found valid and infringed PLEASANTON, Calif., March 3, 2025 /PRNewswire/ — 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the United States District Court for the District
H&E Equipment Services, Inc. BATON ROUGE, La., Aug. 13, 2024 (GLOBE NEWSWIRE) — H&E Equipment Services, Inc. (NASDAQ: HEES) announced that its Board of Directors declared a regular quarterly cash dividend on August 12, 2024, to be paid to its stockholders. The Company announced a quarterly cash dividend of $0.275 per share of common stock
MKS Instruments, Inc. ANDOVER, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on September 6, 2024, to shareholders of record as of August